The CM Group, LLC, a leading provider of information and knowledge services to the biopharmaceutical community, announces the acquisition of Scientific Commercialization, LLC (SC), a Madison, Wisconsin-based leader in medical affairs consulting and business intelligence software solutions. The acquisition will offer a significant advantage to life science companies by providing a comprehensive suite of offerings coupled with the personalized, high-touch service both companies are known for.
Founded in Boston in 2007, ClearView can be likened to a McKinsey & Co. or LEK Consulting – but exclusively for the life sciences industry.
VMG Health, the market leader in providing full-service healthcare transaction advisory and consulting, is pleased to announce it has acquired Health Care Futures, a business strategy and consulting firm with offices in Minneapolis and Chicago. The transaction was recently closed, and the two firms will be fully integrated in the first quarter of 2021. VMG Health is owned by VMG Employees and Northlane Capital Partners, LLC (“NCP”). Health Care Futures was founded in 1996, with a focus to meet the needs of healthcare executives and board members by providing creative strategy and innovative business advice for both current and anticipated challenges.
Nordic, a top-rated healthcare consulting firm, announced Wednesday its acquisition of Bails & Associates, an industry-leading ERP consulting firm that specializes in Infor solutions for customers across a variety of industries, with a concentration in healthcare. Bails will continue to maintain operations out of its headquarters in Canonsburg, Pa. and serve customers under the Bails brand, which is now part of the Nordic family of brands. With this acquisition, Nordic will bring Bails’ ERP solutions to its current customer base of nearly 300 healthcare organizations, helping clients align their system capabilities and operational efficiencies to successfully achieve their business objectives.
CODY®, a Tampa, Florida-based healthcare technology and consulting firm, has acquired Madena™ in a transaction valued at $7.3 million. Madena, a recognized consulting and software leader with an emphasis on enrollment, billing and reconciliation, is best known for its enrollment and reconciliation software, Synchronicity™. “The combination of our products, services and industry expertise provides health plans serving the Medicare, Medicaid and commercial markets an end-to-end integrated solution previously not available in today’s market,” said Deb Mabari, CODY’s founder and Chief Executive Officer.
Baird Capital announced today the sale of portfolio company Prescient Healthcare Group (“Prescient”) to Bridgepoint Development Capital (“Bridgepoint”), the international alternative asset fund management group. Following the transaction, Baird Capital will continue to hold a minority interest in Prescient. The terms of the transaction were not disclosed. Prescient is headquartered in London and has additional offices in the U.S., India and China. The business is a global provider of pharmaceutical intelligence, insights and product strategy.
HG Vision, a vision care consultancy dedicated to the growth and success of independent optometry, has announced an equity investment in The Power Practice, a leading industry consulting company led by Dr Gary Gerber. Details of the transaction were not disclosed. HG Vision is led by industry veterans Dr. April Jasper, Dr. Katie Spear, Joe Colucci and David Jasper. Dr. Jasper is a highly respected, well known practice development expert and thought leader with a practice in Florida.
Surgical Directions, a healthcare solutions company focusing on consulting, leadership, and analytics, announced Tuesday that the executive management team has reached an agreement with Mednax, Inc. for a management buyout. Following this transaction, Surgical Directions will operate independently of Mednax. Terms of the transaction were not disclosed.
Blue Matter is pleased to announce its acquisition of AIM, a specialized firm providing supply chain consultancy and interim management services to life science companies. AIM specializes in building European supply chain infrastructures for new entrants into Europe. This acquisition provides a strategic complement to Blue Matter’s offerings and enhances its PathfinderSM suite of capabilities, designed to help biopharma companies enter European markets and succeed.
Precision Medicine Group (“PMG”) announced today it has acquired Project Farma, a patient-focused bioengineering services firm that supports life science innovators in the manufacturing and scale-up of advanced therapies. Project Farma provides Precision a market-leading expertise in the manufacturing of life-changing medicines, with a unique focus in the rapidly growing area of cell and gene therapy. The acquisition adds Project Farma’s unique expertise to Precision’s suite of end-to-end cell and gene therapy capabilities to support development and commercialization.
What We Do
Who We Are
How We Work
Who We Help
Get In Touch
Connect With Us
Subscribe to Our Daily Note
We publish a Daily Note that aggregates M&A activity, notable developments, regulatory changes, and conferences we deem to be of interest to our partners. It is a quick afternoon read and an easy way to keep your finger on the pulse of the healthcare space. Please fill in your name and email address below if you wish to subscribe.